Arcus Biosciences, Inc. Common Stock (NY:RCUS)

24.46 +0.02 (+0.08%)

Delayed Quote Updated: 11:59 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Arcus Biosciences Announces New Employment Inducement Grants

August 24, 2021

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

August 10, 2021

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights

August 05, 2021

From Arcus Biosciences, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Arcus Biosciences to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conference

August 04, 2021

From Arcus Biosciences

Via Business Wire

Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights

July 29, 2021

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

July 26, 2021

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership ↗

July 20, 2021

An Arcus executive jumped ship for a role at Gilead, but RCUS stock popped Tuesday on expectations for a closer relationship.

Via Investor's Business Daily

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

July 12, 2021

From Arcus Biosciences

Via Business Wire

Why Arcus Biosciences' Big Reveal Wasn't Very Exciting ↗

June 25, 2021

No news from Arcus Biosciences is bad news for the company and other industry heavyweights.

Via The Motley Fool

45 Biggest Movers From Yesterday ↗

June 25, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads...

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

June 24, 2021

From Arcus Biosciences

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 24, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 27.11% to $4.5 during Thursday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

June 24, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne...

Via Benzinga

Here's Why Arcus Biosciences Stock Is Rising Today ↗

June 24, 2021

Investors expecting Gilead Sciences to license Arcus Biosciences' lead asset could be in for an unpleasant surprise.

Via The Motley Fool

Arcus Biosciences Rockets, But Vague Update In Cancer Study Divides Analysts ↗

June 24, 2021

Arcus Biosciences offered a vague update on its lung cancer regimens Wednesday, but RCUS stock rocketed on Thursday.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Open Higher; Accenture Reports Upbeat Q3 Results ↗

June 24, 2021

Following the market opening Thursday, the Dow traded up 0.76% to 34,130.38 while the NASDAQ rose 0.75% to 14,379.10. The S&P also rose, gaining 0.54% to 4,264.62. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 24, 2021

Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...

Via Benzinga

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗

June 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

June 24, 2021

Goldman Sachs boosted Lear Corporation (NYSE:LEA) pr...

Via Benzinga

25 Stocks Moving in Thursday's Pre-Market Session ↗

June 24, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its...

Via Benzinga

7 Stocks Moving In Wednesday's After-Hours Session ↗

June 23, 2021

Gainers Applied Genetic Technologies (NASDAQ: AGTC) shares are trading higher after the company announced that it plans to release 12-month data for adult patients and low-dose...

Via Benzinga

Anti-TIGIT Domvanalimab-Based Combinations Showed Encouraging Clinical Activity in People with Metastatic, PDL1-High Non-Small Cell Lung Cancer at First Interim Analysis of Arcus Biosciences’ Randomized Phase 2 ARC-7 Study

June 23, 2021

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

June 09, 2021

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

May 25, 2021

From Arcus Biosciences, Inc.

Via Business Wire

Arcus Biosciences Presents Early Data from ARC-6, a Phase 1b/2 Study Evaluating Etrumadenant-Based Combinations in Metastatic Castrate-Resistant Prostate Cancer at the 2021 ASCO Annual Meeting

May 19, 2021

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

May 11, 2021

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights

May 05, 2021

From Arcus Biosciences

Via Business Wire

Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More ↗

May 02, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.